Framingham, MA, United States of America

Myra L Patchen


Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Myra L Patchen: Innovator in High Molecular Weight β-Glucans

Introduction:

In the realm of biomedical and pharmaceutical innovations, Myra L Patchen emerges as a prominent inventor and researcher. Hailing from Framingham, MA, Patchen has dedicated her career to developing treatment and prevention methods for infections using soluble β-glucan compositions with very high molecular weights (VHMW-glucan). With her extensive experience in companies like Biopolymer Engineering, Inc. and Biopolymer Engineering Pharmaceutical, Inc., Patchen has made significant contributions to the field of medical research.

Patent: VHMW-Glucans for Infection Treatment:

Myra L Patchen's most notable invention is the composition and therapeutic methods involving very high molecular weight β-glucans. She developed an innovative technique to treat and prevent infections in both animals and humans by administering soluble β-glucan compositions. These compositions consist of β-glucan molecules with an average molecular weight of at least 1,000,000 daltons, as determined by multi-angle laser light scattering. By harnessing the properties of VHMW-glucans, Patchen has opened up new avenues for combating infections effectively.

Contributions and Collaborations:

Throughout her career, Patchen has collaborated with esteemed researchers and coworkers to further her research on VHMW-glucans. Notably, she has worked closely with Spiros Jamas and D Davidson Easson, Jr., who have likely played significant roles in the development and implementation of these innovative methods for infection treatment and prevention. Their collective efforts have led to major advancements in the understanding and application of high molecular weight β-glucans in the medical field.

Conclusion:

Myra L Patchen's commitment to medical research and innovation has resulted in several valuable patents, particularly in the field of VHMW-glucans for infection treatment and prevention. Her contributions have opened up new possibilities for designing therapeutics and prophylactic methods to combat infections more effectively. As the healthcare industry continues to evolve, Patchen's pioneering work serves as a testament to the power of innovative thinking and dedication in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…